Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Frontline Plc Ordinary Shares (FRO) vs Liquidia Corporation Common Stock (LQDA) Price & Performance

Frontline Plc Ordinary SharesTrade
Liquidia Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Frontline Plc Ordinary Shares vs Liquidia Corporation Common Stock — how do they compare? Frontline Plc Ordinary Shares trades at $54.5 (market cap $13.14B), while Liquidia Corporation Common Stock trades at $34.5 (market cap $2.40B). The key difference: Frontline Plc Ordinary Shares is far larger — about 5.5× Liquidia Corporation Common Stock's market cap, and Frontline Plc Ordinary Shares pays a 9.11% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Frontline Plc Ordinary Shares for 1 Days and Liquidia Corporation Common Stock for 0 Days on average.

FROLQDA
Market Cap
$13.14B$2.40B
Volume
3,351,5472,857,547
Sector
IndustrialsHealth
52-Week High
$59.19$91.03
52-Week Low
$20.58$22.02
Typical Hold Time
1 Days0 Days
Enterprise Value
$15.26B$2.30B
Dividend Yield
9.11%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Frontline Plc Ordinary Shares

Frontline (FRO) trades at $59.04, down 0.25% on the day, but maintains a strong technical and fundamental position. The stock is near its 52-week high, supported by bullish moving averages and robust earnings, with Q2 2026 EPS beating estimates at $2.96. Revenue and profitability have surged, with 2026 net income margin projected at 54.75%. Recent news highlights a special dividend declaration and institutional buying interest.

The outlook for FRO is positive, driven by record earnings and favorable shipping market dynamics. Investment opportunities include strong cash flow generation and shareholder returns, but risks involve exposure to volatile freight rates and geopolitical tensions affecting global trade. Analyst sentiment is mixed, with a 'Hold' consensus suggesting cautious optimism amid near-term highs.

Liquidia Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FRO
10% Buy90% Sell
Avg holding period · 1 Days
LQDA
62% Buy38% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Frontline Plc Ordinary Shares

Frontline operates a fleet of oil tankers that transport crude oil by sea. Its vessels serve global energy trading routes.

Read more on FRO →

About Liquidia Corporation Common Stock

Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.

Read more on LQDA →